Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Happel Insider Profile
11 Followers
David Happel, CCO at Raptor Pharmaceutical Corp., holds 639.20K shares in Sagimet Biosciences, Inc. Class A (Ticker: SGMT), holds 5.09K shares in Horizon Therapeutics (Ticker: HZNP), holds 5.23K shares in Raptor Pharmaceutical Corp. (Ticker: RPTP). Most recently, David Happel Bought ― shares of Sagimet Biosciences, Inc. Class A on Mar 28, 2024 for an estimated value of 63.65K.
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+14.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that David Happel holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 20, 2023 - Today
Return:+43.50%
The most profitable trade made by David Happel
David Happel's Trading History
Raptor Pharmaceutical Corp.
Mar 03, 2016
―
Uninformative Sell
1.98K
$47.06K
Horizon Therapeutics
Oct 26, 2017
―
Uninformative Buy
56.15K
$591.85K
Sagimet Biosciences, Inc. Class A
Mar 28, 2024
President & CEO, Director
Informative Buy
63.65K
$2.92M
List of latest transactions for each holding click on a transaction to see David Happel's performance on stock
You May Also Like
David Happel insider profile FAQ
What is the percentage of profitable transactions made by David Happel?
The percentage of profitable transactions made by David Happel is 67%.
What is the average return per transaction made by David Happel?
The average return per transaction made by David Happel is 14.10%.
What stocks does David Happel hold?
David Happel holds: RPTP, HZNP, SGMT stocks.
What was David Happel’s latest transaction?
David Happel latest transaction was an Informative Buy of $63.65K.
What was David Happel's most profitable transaction?
David Happel’s most profitable transaction was an Informative Buy of SGMT stock on November 20, 2023. The return on the trade was 43.50%.
What is David Happel's role in Raptor Pharmaceutical Corp.?
David Happel's role in Raptor Pharmaceutical Corp. is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.